Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001714899-19-000018
Filing Date
2019-03-12
Accepted
2019-03-13 13:53:18
Documents
4
Effectiveness Date
2019-03-13

Document Format Files

Seq Description Document Type Size
1 S-3ASR forms-3asr31219.htm S-3ASR 193291
2 EXHIBIT 5.1 exhibit51.htm EX-5.1 20150
3 EXHIBIT 23.2 exhibit232.htm EX-23.2 2665
4 dnlilogo.jpg GRAPHIC 30236
  Complete submission text file 0001714899-19-000018.txt   258777
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-230232 | Film No.: 19677879
SIC: 2836 Biological Products, (No Diagnostic Substances)